Position in JNJ
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$16,413,827
+$3,035,871 QoQ
Shares Held
64,629
+18.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#840
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026INTACT INVESTMENT MANAGEMENT INC. holds $106,940,186 across 8 Drug Manufacturers - General names. JNJ ranks #3 (15.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
202,100 | $25,969,850 | |
| 2 | ABBV |
AbbVie Inc.
|
95,230 | $23,963,677 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
64,629 | $16,413,827 | |
| 4 | PFE |
Pfizer Inc
|
679,300 | $16,357,544 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
89,900 | $11,357,966 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
148,700 | $8,568,094 | |
| 7 | AMGN |
Amgen Inc
|
11,900 | $4,309,228 | |
| 8 | LLY |
ELI LILLY & Co
|
0 | $0 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,413,827 | 64,629 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $13,377,956 | 54,729 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $11,326,166 | 54,729 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $10,592,859 | 57,129 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $10,904,669 | 71,389 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $14,476,007 | 87,289 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $12,233,261 | 84,589 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $14,878,566 | 91,809 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $10,887,312 | 74,489 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $9,964,229 | 62,989 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $10,531,203 | 67,189 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $13,532,961 | 86,889 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $15,145,080 | 91,500 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $13,485,000 | 87,000 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $11,658,900 | 66,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $10,912,448 | 66,800 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $11,094,375 | 62,500 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $11,378,166 | 64,200 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $13,428,995 | 78,500 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $12,677,750 | 78,500 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $12,932,090 | 78,500 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $12,901,475 | 78,500 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $12,621,876 | 80,200 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $11,448,872 | 76,900 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $10,153,486 | 72,200 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $10,346,157 | 78,900 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||